Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 8—August 2021

African Horse Sickness Virus Serotype 1 on Horse Farm, Thailand, 2020

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Napawan Bunpapong, Kamonpan Charoenkul, Chanakarn Nasamran, Ekkapat Chamsai, Kitikhun Udom, Supanat Boonyapisitsopa, Rachod Tantilertcharoen, Sawang Kesdangsakonwut, Navapon Techakriengkrai, Sanipa Suradhat, Roongroje Thanawongnuwech, and Alongkorn AmonsinComments to Author 
Author affiliation: Chulalongkorn University, Bangkok, Thailand

Cite This Article


To investigate an outbreak of African horse sickness (AHS) on a horse farm in northeastern Thailand, we used whole-genome sequencing to detect and characterize the virus. The viruses belonged to serotype 1 and contained unique amino acids (95V,166S, 660I in virus capsid protein 2), suggesting a single virus introduction to Thailand.

African horse sickness virus (AHSV) is an RNA virus of the family Reoviridae, genus Orbivirus. AHSV can be classified into 9 serotypes according to virus capsid protein (VP) 2 (1). Serotypes 1–8 have been reported from restricted areas of sub-Saharan Africa only. Serotype 9 is more widespread and causes epidemics outside Africa. Serotype 4 caused outbreaks in Spain and Portugal during 1987–1990 (2).

In Thailand, the first AHS outbreak was reported in March 2020 in northeastern Thailand (35). AHS outbreaks have been reported in 17 provinces of Thailand, affecting ≈2,700 horses (Appendix Table 1) (6). We report a comprehensive outbreak investigation of emerging AHSV and whole-genome characterization of AHSV recovered from a horse farm in northeastern Thailand.

The Study

In March 2020, the Veterinary Diagnostic Laboratory at Chulalongkorn University (Bangkok, Thailand) was notified of unusual horse deaths on a recreational horse farm, which encompasses up to 6,400 m2, in Nakhon Ratchasima Province, northeastern Thailand. A total of 49 horses (2 thoroughbred, 21 miniature, 26 native horses) were kept on free range. Other animals on the farm were 3 dogs, 3 rabbits, 3 pigs, and 8 peacocks. The outbreak investigation and sample collection were conducted under the approval of Institutional Animal Care and Use Committee protocol no. 2031050.

Figure 1

Gross lesions from horses affected by African horse sickness, Thailand, 2020. A) Mild edema at the supraorbital fossa with frothy exudate from the nostrils; B) yellow, gelatinous infiltrations and perineural edema of the intramuscular tissues; C) right axillary subcutaneous edema; D) periaortic edema and hemorrhage; E) subendocardial petechiae and ecchymoses of the heart.

Figure 1. Gross lesions from horses affected by African horse sickness, Thailand, 2020. A) Mild edema at the supraorbital fossa with frothy exudate from the nostrils; B) yellow, gelatinous infiltrations and perineural...

On March 20, 2020, the outbreak began when horses showed severe clinical signs including depression, fever, dyspnea, and subcutaneous edema in the temporal or supraorbital area, followed by sudden death within 48 hours. On March 28, we visited the horse farm, implemented insect-proof housing, and collected a blood sample from a horse with clinical signs (horse CU-1), which died the next day. We performed necropsies on 2 horse carcasses (CU-2 and CU-3) and collected 7 tissue samples. Gross lesions showed frothy exudate in the bronchial lumen and mild edema of the supraorbital sinus and conjunctiva. We observed intermuscular and perineural edema at the axillary region and subcutaneous muscle, periaortic edema, and subendocardial hemorrhage (Figure 1). Histopathologic slides showed congestion of the spleen, liver, lymph nodes, and lung; no other remarkable lesions were observed. The outbreak lasted 3 weeks and affected 30 horses (last case on April 10). On April 26, horses on the farm were vaccinated with polyvalent, live-attenuated AHSV vaccine (Ondersterpoort Biological Products,; no horses showed clinical signs after vaccination and implementation of insect-proof housing. In total, during the 3 weeks of the outbreak, the mortality rate for horses on the farm was 61.22% (30 deaths/49 horses) (Appendix Table 2). Mortality rates by breed were 100% (2/2) for thoroughbreds, 76.19% (16/21) for miniature horses, and 46.15% (12/26) for native horses. The same management practices were applied for horses of all breeds.

We visited the horse farm again on May 30 (1 month after vaccination) and August 1 (3 months after vaccination). From the remaining horses we collected 18 serum samples at each visit (total 36). All samples were tested for antibodies against AHSV by blocking ELISA specific to VP7 (INgezim AHSV Compac Plus; Eurofins Technologies, (Appendix). All 36 serum samples were positive for AHSV antibodies (Appendix Table 3).

To identify AHSV, we extracted viral RNA from 8 blood and tissue samples by using the GeneAll GENTi Viral DNA/RNA Extraction Kit (GeneAll, We performed real-time reverse transcription PCR (RT-PCR) with VP7 gene–specific primers and probes by using the SuperScript III Platinum One-Step qRT-PCR System (Thermo Fisher, (Appendix) (7). All 8 samples were positive for AHSV (cycle threshold 28.29–33.91). In detail, blood samples from horse CU-1; lymph nodes from CU-2; and lymph node, lung, spleen, heart, liver, and kidney samples from CU-3 were positive for AHSV (Appendix Table 4). To further characterize AHSV from Thailand, we performed VP2 gene-specific RT-PCR, which showed that the AHSVs from Thailand belong to AHSV serotype 1 (8). We next subjected the spleen from horse CU-3 to whole-genome sequencing and 2 additional viruses (from CU-1 and CU-2) to VP2 and nonstructural gene (NS) 3 gene sequencing (Table). We conducted whole-genome sequencing by amplifying viral fragments and sequencing by using MinION Oxford Nanopore technologies ( (Appendix Table 5) (9). The nucleotide sequences of the AHSVs from Thailand were submitted to GenBank (accession nos. MW387422–35). Nucleotide sequences of AHSV from Thailand were pairwise compared against those of vaccine and reference viruses. We found that the whole genome of Thailand AHSV (virus CU-3) possessed high nucleotide identities (99.40%–100%) to the reference Thailand AHSV-1 (110983/63 and TAI2020/01). For the VP2 gene, Thailand AHSV possessed 99.90% nucleotide identities among them; the highest nucleotide identity (99.90%) was to the reference Thailand AHSV-1 (110983/63 and TAI2020/01, 02, and 03). The nucleotide identities of VP2 between Thailand AHSV and the reference AHSV of serotypes 2–9 were low (54.60%–67.10%). For the NS3 gene, Thailand AHSV had 99.90% nucleotide identities; the highest nucleotide identity was to the reference South Africa AHSV of clade gamma (97.10%–99.90%) (Appendix Table 6).

Figure 2

Phylogenetic trees for AHSV, Thailand, 2020. A) Viral capsid protein 2; B) nonstructural gene 3. Purple circles indicate Thailand AHSV characterized in this study; blue squares indicate AHSV vaccine strains; numbers after AHSV indicate serotypes. Scale bars indicate nucleotide substitutions per site. AHSV, African horse sickness virus.

Figure 2. Phylogenetic trees for AHSV, Thailand, 2020. A) Viral capsid protein 2; B) nonstructural gene 3. Purple circles indicate Thailand AHSV characterized in this study; blue squares indicate AHSV vaccine strains;...

For phylogenetic analysis, we included the VP2 sequences of the Thailand AHSV and reference viruses (AHSV-1 vaccine strains and AHSV serotypes 1–9). For phylogenetic analysis of NS3, we included the NS3 sequences of Thailand AHSV and reference viruses of alpha, beta, and gamma clades. The maximum clade credibility trees for VP2 and NS3 genes were constructed by using BEAST 2.0 ( with the Bayesian Markov chain Monte Carlo algorithm (Appendix). Phylogenetic analysis of the VP2 gene showed that Thailand AHSV was clustered in AHSV serotype 1 but not in other clusters (serotypes 2–9). For NS3, the Thailand AHSVs were grouped within the gamma clade, similar to the references AHSV-1 and AHSV-2 (Figure 2). We analyzed amino acid determinants of VP2 and NS3 at 2 neutralizing epitopes (residues 321–339 and 377–400) (10). Thailand AHSV had identical amino acids at positions 321–339 and 377–400 among Thailand AHSVs and some reference AHSV-1 but differed from the reference vaccine strains (HS29/62 and OBP-116). The deduced amino acids related to the virulence of AHSV at positions 357 of VP2 and 165–168 and 201 of NS3 were also analyzed (1,11). Thailand AHSV contained virulence-related amino acids at VP2–357N and NS3–201M, which were not observed in some reference AHSV-1 and AHSV vaccines (Appendix Table 7). Of note, all Thailand AHSVs contained unique amino acids at positions 95V, 166S, and 660I, suggesting a single introduction from the same AHSV ancestor into Thailand.


We speculate that AHSV serotype 1 potentially spread outside Africa from imported subclinically infected animals, such as zebras. The Thailand government implemented control measures to prevent further spread, including movement restrictions, quarantine, disinfection, and vector control. Moreover, to prevent spread in Thailand and neighboring countries, mass vaccination of equids with a live-attenuated AHSV vaccine was conducted. The AHSV from Thailand possessed unique amino acids, suggesting a single introduction of the virus to the country. This information will be useful for strategic planning for disease prevention and control, vaccine selection, and diagnostic assay development.

Dr. Bunpapong is a PhD candidate at the Department of Veterinary Public Health and a senior veterinarian at the Veterinary Diagnostic Laboratory, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand. Her research interests include emerging and reemerging infectious diseases in animals.



We thank the horse farm owner and workers for their cooperation and assistance during the outbreak investigation.

Chulalongkorn University supported the Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and the One Health Research cluster. This research was partially funded by Chulalongkorn University TSRI Fund (CU_FRB640001_01_31_1), the Agricultural Research Development Agency fund (PRP6405031220), and the PMU-B (NXPO) fund (B17F640011). The Thailand Research Fund provided financial support to the TRF Senior Scholar to author A.A. (RTA6080012).



  1. Potgieter  AC, Wright  IM, van Dijk  AA. Consensus sequence of 27 African horse sickness virus genomes from viruses collected over a 76-year period (1933 to 2009). Genome Announc. 2015;3:e0092115. DOIPubMedGoogle Scholar
  2. Mellor  PS, Hamblin  C. African horse sickness. Vet Res. 2004;35:44566. DOIPubMedGoogle Scholar
  3. King  S, Rajko-Nenow  P, Ashby  M, Frost  L, Carpenter  S, Batten  C. Outbreak of African horse sickness in Thailand, 2020. Transbound Emerg Dis. 2020;tbed.13701.
  4. Lu  G, Pan  J, Ou  J, Shao  R, Hu  X, Wang  C, et al. African horse sickness: Its emergence in Thailand and potential threat to other Asian countries. Transbound Emerg Dis. 2020;tbed.13625; Epub ahead of print. DOIPubMedGoogle Scholar
  5. Castillo-Olivares  J. African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination. Equine Vet J. 2021;53:914. DOIPubMedGoogle Scholar
  6. World Animal Health Information System, World Organisation for Animal Health. Animal disease events. African horse sickness, Thailand [cited 2020 Dec 30].
  7. Guthrie  AJ, Maclachlan  NJ, Joone  C, Lourens  CW, Weyer  CT, Quan  M, et al. Diagnostic accuracy of a duplex real-time reverse transcription quantitative PCR assay for detection of African horse sickness virus. J Virol Methods. 2013;189:305. DOIPubMedGoogle Scholar
  8. Maan  NS, Maan  S, Nomikou  K, Belaganahalli  MN, Bachanek-Bankowska  K, Mertens  PP. Serotype specific primers and gel-based RT-PCR assays for ‘typing’ African horse sickness virus: identification of strains from Africa. PLoS One. 2011;6:e25686. DOIPubMedGoogle Scholar
  9. Quan  M, van Vuuren  M, Howell  PG, Groenewald  D, Guthrie  AJ. Molecular epidemiology of the African horse sickness virus S10 gene. J Gen Virol. 2008;89:115968. DOIPubMedGoogle Scholar
  10. Martínez-Torrecuadrada  JL, Langeveld  JPM, Meloen  RH, Casal  JI. Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides. J Gen Virol. 2001;82:241524. DOIPubMedGoogle Scholar
  11. van Staden  V, Smit  CC, Stoltz  MA, Maree  FF, Huismans  H. Characterization of two African horse sickness virus nonstructural proteins, NS1 and NS3. Arch Virol Suppl. 1998;14:2518. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2708.210004

Original Publication Date: July 15, 2021

Table of Contents – Volume 27, Number 8—August 2021

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Alongkorn Amonsin, Center of Excellence for Emerging and Reemerging Infectious Diseases in Animals (CUEIDAs) and One Health Research Cluster, Chulalongkorn University, Bangkok 10330, Thailand

Send To

10000 character(s) remaining.


Page created: June 09, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.